Literature DB >> 20303296

The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.

Md Hasan Zaki1, Kelli L Boyd, Peter Vogel, Michael B Kastan, Mohamed Lamkanfi, Thirumala-Devi Kanneganti.   

Abstract

Decreased expression of the Nlrp3 protein is associated with susceptibility to Crohn's disease. However, the role of Nlrp3 in colitis has not been characterized. Nlrp3 interacts with the adaptor protein ASC to activate caspase-1 in inflammasomes, which are protein complexes responsible for the maturation and secretion of interleukin-1beta (IL-1beta) and IL-18. Here, we showed that mice deficient for Nlrp3 or ASC and caspase-1 were highly susceptible to dextran sodium sulfate (DSS)-induced colitis. Defective inflammasome activation led to loss of epithelial integrity, resulting in systemic dispersion of commensal bacteria, massive leukocyte infiltration, and increased chemokine production in the colon. This process was a consequence of a decrease in IL-18 in mice lacking components of the Nlrp3 inflammasome, resulting in higher mortality rates. Thus, the Nlrp3 inflammasome is critically involved in the maintenance of intestinal homeostasis and protection against colitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303296      PMCID: PMC2982187          DOI: 10.1016/j.immuni.2010.03.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  57 in total

1.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

2.  Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Authors:  L Sutherland; J Singleton; J Sessions; S Hanauer; E Krawitt; G Rankin; R Summers; H Mekhjian; N Greenberger; M Kelly
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

Review 4.  Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar.

Authors:  J M Rhodes
Journal:  Lancet       Date:  1996-01-06       Impact factor: 79.321

5.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

6.  IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.

Authors:  J C Keith; L Albert; S T Sonis; C J Pfeiffer; R G Schaub
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

7.  Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.

Authors:  D K Podolsky; K J Isselbacher
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

8.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.

Authors:  P Li; H Allen; S Banerjee; S Franklin; L Herzog; C Johnston; J McDowell; M Paskind; L Rodman; J Salfeld
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

9.  Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis.

Authors:  M J Palmen; L A Dieleman; M B van der Ende; A Uyterlinde; A S Peña; S G Meuwissen; E P van Rees
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

10.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

Authors:  K Kuida; J A Lippke; G Ku; M W Harding; D J Livingston; M S Su; R A Flavell
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

View more
  424 in total

1.  The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair.

Authors:  Kenta Moriwaki; Sakthi Balaji; Thomas McQuade; Nidhi Malhotra; Joonsoo Kang; Francis Ka-Ming Chan
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 3.  Immunoregulation by the gut microbiota.

Authors:  Junko Nishio; Kenya Honda
Journal:  Cell Mol Life Sci       Date:  2012-04-22       Impact factor: 9.261

4.  The inflammasome: a remote control for metabolic syndrome.

Authors:  Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Cell Res       Date:  2012-04-10       Impact factor: 25.617

Review 5.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 6.  Expression and functional importance of innate immune receptors by intestinal epithelial cells.

Authors:  Rute Marques; Ivo G Boneca
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

Review 7.  Establishment of intestinal homeostasis during the neonatal period.

Authors:  Silvia Stockinger; Mathias W Hornef; Cécilia Chassin
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

8.  Mucosal immunology: Inflammasome activation in the gut.

Authors:  Olive Leavy
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

9.  B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage.

Authors:  Donna Kirkland; Alicia Benson; Julie Mirpuri; Reed Pifer; Baidong Hou; Anthony L DeFranco; Felix Yarovinsky
Journal:  Immunity       Date:  2012-02-01       Impact factor: 31.745

10.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.